Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Jungeui Hong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-5998-2102; OpenAlex author ID A5086132863. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 3 papers

Papers 12

  1. Genomic evolution of pancreatic cancer at single-cell resolution. Co-author DOI 10.1038/s41588-025-02468-9↗
  2. Transcriptomic Plasticity Is a Hallmark of Metastatic Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-1117↗
  3. Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0772↗
  4. The Evolutionary Forest of Pancreatic Cancer. First author DOI 10.1158/2159-8290.cd-23-1541↗
  5. The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions. Co-author DOI 10.1158/2767-9764.crc-24-0167↗
  6. Application of high-throughput single-nucleus DNA sequencing in pancreatic cancer. Co-author DOI 10.1038/s41467-023-36344-z↗
  7. The pancreatic cancer genome revisited. First author DOI 10.1038/s41575-021-00463-z↗
  8. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  9. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/2020.09.11.294389↗
  10. The Evolutionary Origins of Recurrent Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-19-1508↗
  11. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗
  12. Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer. Co-author DOI 10.1038/ng.3764↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 12 shared papers, 2017–2026 · strength 1.90
  2. Akimasa Hayashi · 10 shared papers, 2019–2026 · strength 1.57
  3. Eileen Mary O'Reilly · 7 shared papers, 2020–2026 · strength 1.20
  4. Alvin P. Makohon-Moore · 8 shared papers, 2017–2025 · strength 0.94
  5. Haochen Zhang · 4 shared papers, 2023–2026 · strength 0.87
  6. Laura DeLong Wood · 6 shared papers, 2017–2026 · strength 0.76
  7. Zachary A. Kohutek · 5 shared papers, 2017–2026 · strength 0.67
  8. Wungki Park · 3 shared papers, 2025–2026 · strength 0.67
  9. Caitlin A. McIntyre · 3 shared papers, 2023–2026 · strength 0.59
  10. Marc A. Attiyeh · 6 shared papers, 2017–2025 · strength 0.57
  11. Benjamin J. Raphael · 2 shared papers, 2025–2026 · strength 0.43
  12. Hitomi Sakamoto · 4 shared papers, 2019–2025 · strength 0.43
  13. Katelyn Mullen · 2 shared papers, 2023–2025 · strength 0.36
  14. Ralph H. Hruban MD · 4 shared papers, 2017–2020 · strength 0.28
  15. Marsha Reyngold · 1 shared paper, 2026 · strength 0.28
  16. Christopher H. Crane · 1 shared paper, 2026 · strength 0.28
  17. Dana Pe'er · 1 shared paper, 2026 · strength 0.23
  18. Arnav Mehta · 1 shared paper, 2026 · strength 0.23
  19. Alejandro Jiménez-Sánchez · 1 shared paper, 2026 · strength 0.23
  20. Marc Hilmi · 1 shared paper, 2026 · strength 0.23
  21. Alice Chia-Chi Wei · 1 shared paper, 2026 · strength 0.23
  22. Johannes G. Reiter · 3 shared papers, 2017–2020 · strength 0.23
  23. Marinela Capanu · 1 shared paper, 2025 · strength 0.20
  24. Olca Baştürk · 2 shared papers, 2019–2020 · strength 0.15
  25. Yi Zhong · 2 shared papers, 2019–2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.